首页 News 正文

Enable the people to enjoy better medical and health benefits! Chen Jining Meets with AstraZeneca CEO Su Boke from the UK

lfuuxml
3672 0 0

This morning, Chen Jining, Secretary of the Municipal Party Committee, met with Su Boke, Global Executive Director and CEO of AstraZeneca UK, and his delegation.
Chen Jining introduced the modernization construction and biopharmaceutical development in Shanghai. He said that in the final analysis, to promote Chinese path to modernization is to make people live a better life. Biopharmaceuticals is one of the three leading industries that Shanghai is focusing on developing. Since last year, multiple innovative policies have been introduced, providing strong support to enterprises in research and development facilitation, innovative drug device listing, and clinical trials, promoting new breakthroughs, and enabling the people to enjoy better medical and health benefits. AstraZeneca is a leading pharmaceutical company globally. We welcome development opportunities and will closely integrate our own advantages with Shanghai's market advantages, scientific and technological innovation advantages, clinical advantages, talent advantages, etc. on the basis of existing good cooperation. We will continue to increase investment and layout efforts, deepen innovative project cooperation and docking, and strive to provide higher quality medical and health products and services. We will make every effort to create a first-class business environment that is market-oriented, legal, and internationalized, and provide comprehensive and high-quality services for global enterprises and talent teams to cultivate and develop in Shanghai and Shenzhen.
Su Boke introduced the progress and future development plans of AstraZeneca's business in Shanghai. He said that setting the company's Asia Pacific headquarters, China headquarters, and global R&D center in Shanghai is precisely because of the importance of the Chinese market, especially Shanghai, to AstraZeneca. The purpose of leading the global senior management team to Shanghai this time is to deepen the team's understanding of China and Shanghai, strengthen their confidence in developing in China and Shanghai, continue to increase innovation investment, expand new business layout, carry out more in-depth cooperation with Chinese local innovative pharmaceutical enterprises, and contribute more to promoting high-quality development of Shanghai pharmaceutical industry and better benefiting global patients.
City leaders Li Zheng and Liu Duo attended the meeting.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

  • 【科技记者古尔曼:苹果计划于12月第一周发布iOS 18.2系统更新 带来更多人工智能功能】科技记者古尔曼透露,苹果计划于12月第一周发布iOS 18.2系统更新。iOS 18.2将为iPhone 15 Pro机型和所有iPhone 16机型带来更多 ...
    cristianna
    昨天 17:32
    支持
    反对
    回复
    收藏
  •   近日,爱立信中国区总裁方迎在接受《经济参考报》记者采访时表示,5G技术在全球范围内得到了迅速发展,但面临商业潜力未能充分挖掘、网络运营难度较以往更高两大挑战。因此,运营商在继续5G网络部署的同时,应关 ...
    blueskybb
    昨天 15:05
    支持
    反对
    回复
    收藏
  • 【特斯拉首次聘请了一位品牌大使】特斯拉近日公布了首位品牌大使韩国奥运射击选手金艺智,这一举动有些出人意料,毕竟它曾经对广告的态度十分不屑。 ...
    xyyg
    昨天 13:34
    支持
    反对
    回复
    收藏
  •   证券时报网讯,纽约州共同退休基金在第三季度对一些科技巨头的股票进行了调整。该基金是美国第三大公共养老金,管理着2677亿美元的资产。该基金三季度出售了231,600股Palantir 股票,将其持股数量降至110万股。 ...
    LEMONKEITH
    昨天 15:12
    支持
    反对
    回复
    收藏
lfuuxml 新手上路
  • 粉丝

    0

  • 关注

    0

  • 主题

    0